YD Bio (YDES) Fundamental Analysis: Revenue, Earnings & Valuation

2.63 / 10

Underperform

Fundamental analysis rates YDES as Underperform with a 2.6/10 score. Profit‑MV and Cash‑MV are modestly positive, but revenue‑MV, income‑tax ratio and overall revenue metrics lag, indicating a challenging financial outlook.

Analysis Checks(6/10)

Revenue-MV

Value-0.20

Score1/3

Weight12.61%

1M Return5.44%

Inventory turnover ratio

Value37.80

Score3/3

Weight15.31%

1M Return6.65%

Gross profit margin (%)

Value38.37

Score1/3

Weight0.60%

1M Return0.36%

Profit-MV

Value-0.12

Score2/3

Weight14.40%

1M Return6.36%

Income tax / Total profit (%)

Value17.82

Score1/3

Weight0.35%

1M Return0.21%

Current assets turnover ratio

Value1.16

Score2/3

Weight3.31%

1M Return1.91%

Fixed assets turnover ratio

Value1019.08

Score3/3

Weight3.05%

1M Return1.76%

Cost of sales ratio (%)

Value73.08

Score3/3

Weight7.61%

1M Return4.08%

Asset-MV

Value0.04

Score1/3

Weight28.65%

1M Return11.48%

Cash-MV

Value-0.15

Score2/3

Weight14.11%

1M Return6.19%

Is YDES undervalued or overvalued?

YDES scores 2.63/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, 0.00% net margin, 0.00 P/E ratio, -8617.19 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.